Galidesivir
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-18649A-5 mg |
| CAS # | 249503-25-1 |
| Pricing | 5 mg, USD $2400.0 |
| Synonyms | BCX4430; Immucillin-A |
| MWt | 265.27 |
| Formula | C₁₁H₁₅N₅O₃ |
| Biological Activity | Galidesivir (BCX4430), an adenosine analog and a direct-acting antiviral agent, disrupts viral RNA-dependent RNA polymerase (RdRp) activity. Galidesivir is active in vitro against many RNA viral pathogens, including the filoviruses and emerging infectious agents such as MERS-CoV, SARS-CoV, and SARS-CoV-2. Galidesivir inhibits some negative-sense RNA viruses with EC50s ranging from ~3 to ~68 μM[1][2][3]. |
| Purity | 99.29% |